MEI Pharma, a publicly traded pharmaceutical company, closed a $100 million private placement to turn itself into a litecoin ...

MEI Pharma has taken a major step, becoming the first publicly traded firm on a national exchange to include Litecoin (LTC) as a major treasury reserve asset. Starting with a $100 million private ...

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

MEI Pharma (MEIP) just threw Wall Street a curveball by swapping part of its cash pile for Litecoin (LTC) and inviting ...

MEI Pharma, Inc. (NASDAQ:MEIP) saw its stock more than double following the announcement of a $100 million private placement ...

MEI Pharma unveils bold $100M Litecoin treasury plan with Titan, GSR, Litecoin Foundation, expanding altcoin adoption beyond ...

MEI Pharma has become the first publicly traded company to adopt Litecoin (LTC) as a primary treasury reserve asset.

MEI Pharma announced a $100 million private placement to accumulate Litecoin, as well as the addition of Charlie Lee to its ...

MEI Pharma commits $100M to Litecoin with Charlie Lee joining its board, signaling major institutional interest in LTC.

MEI Pharma unveils a $100M Litecoin treasury initiative, gaining Litecoin Foundation support and boosting shares 50% intraday ...

MEI Pharma announces a $100 million private placement to adopt Litecoin as its primary treasury reserve asset.